These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33547332)

  • 1. Detecting survival-associated biomarkers from heterogeneous populations.
    Saegusa T; Zhao Z; Ke H; Ye Z; Xu Z; Chen S; Ma T
    Sci Rep; 2021 Feb; 11(1):3203. PubMed ID: 33547332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
    Kim D; Li R; Dudek SM; Ritchie MD
    J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the clinical utility of genomic expression data across human cancers.
    Xu X; Huang L; Chan CH; Yu T; Miao R; Liu C
    Oncotarget; 2016 Jul; 7(29):45926-45936. PubMed ID: 27322207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment.
    Zhang W; Ota T; Shridhar V; Chien J; Wu B; Kuang R
    PLoS Comput Biol; 2013; 9(3):e1002975. PubMed ID: 23555212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
    Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
    Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
    [No Abstract]   [Full Text] [Related]  

  • 6. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.
    Liu C; Wang X; Genchev GZ; Lu H
    Methods; 2017 Jul; 124():100-107. PubMed ID: 28627406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
    Li B; Cui Y; Diehn M; Li R
    JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of prognostic biomarkers for major subtypes of non-small-cell lung cancer using genomic and clinical data.
    Lathwal A; Kumar R; Arora C; Raghava GPS
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):2743-2752. PubMed ID: 32661603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study.
    Zhu L; Wang H; Jiang C; Li W; Zhai S; Cai X; Wang X; Liao L; Tao F; Jin D; Chen G; Xia Y; Mao JH; Li B; Wang P; Hang B
    EBioMedicine; 2020 Nov; 61():103023. PubMed ID: 33069062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
    Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
    BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
    Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
    EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative Molecular Analyses of an Individual Transcription Factor-Based Genomic Model for Lung Cancer Prognosis.
    Yao R; Zhou L; Guo Z; Zhang D; Zhang T
    Dis Markers; 2021; 2021():5125643. PubMed ID: 34925645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional screening for ultra-high dimensional covariates with survival outcomes.
    Hong HG; Kang J; Li Y
    Lifetime Data Anal; 2018 Jan; 24(1):45-71. PubMed ID: 27933468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma.
    Gui CP; Wei JH; Chen YH; Fu LM; Tang YM; Cao JZ; Chen W; Luo JH
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34237133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
    Mo W; Ding Y; Zhao S; Zou D; Ding X
    PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer.
    Evans JR; Zhao SG; Chang SL; Tomlins SA; Erho N; Sboner A; Schiewer MJ; Spratt DE; Kothari V; Klein EA; Den RB; Dicker AP; Karnes RJ; Yu X; Nguyen PL; Rubin MA; de Bono J; Knudsen KE; Davicioni E; Feng FY
    JAMA Oncol; 2016 Apr; 2(4):471-80. PubMed ID: 26746117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
    Liu N; Wu Y; Cheng W; Wu Y; Wang L; Zhuang L
    BMC Cancer; 2021 Apr; 21(1):460. PubMed ID: 33902514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico recognition of a prognostic signature in basal-like breast cancer patients.
    Conte F; Sibilio P; Grimaldi AM; Salvatore M; Paci P; Incoronato M
    PLoS One; 2022; 17(2):e0264024. PubMed ID: 35167614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma.
    Chen J; Guo X; Zeng G; Liu J; Zhao B
    Comput Math Methods Med; 2020; 2020():8081973. PubMed ID: 33082842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel gene signatures for prognosis prediction in ovarian cancer.
    Bao M; Zhang L; Hu Y
    J Cell Mol Med; 2020 Sep; 24(17):9972-9984. PubMed ID: 32666642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.